Objectives: In cT1-2N0, oral squamous cell carcinoma (OSCC) occult metastases are detected in 23%-37% of cases. Sentinel lymph node biopsy (SLNB) was introduced in head and neck cancer as a minimally invasive alternative for an elective neck dissection in neck staging. Meta-analyses of SLNB accuracy show heterogeneity in the existing studies for reference standards, imaging techniques and pathological examination. The aim of this study was to assess the sensitivity and negative predictive value (NPV) of the SLNB in detecting occult metastases in cT1-2N0 OSCC in a well-defined cohort. Results: In all cases, SLNs were harvested. A total of 25 (27%) patients had tumour-positive SLNs. The median follow-up was 32 months (range 2-104). Four patients were diagnosed with an isolated regional recurrence in the SLNB negative neck side resulting in an 85% sensitivity and a 94% NPV.
| INTRODUCTION
Regional metastases occur in 23%-37% of the early stage (cT1-2N0) oral squamous cell carcinomas (OSCC). [1] [2] [3] Lymph node status is an important prognostic factor for outcome and treatment decision-making of head and neck cancer. [1] [2] [3] [4] [5] [6] [7] [8] However, not all metastases are clinically detectable with the current diagnostic modalities. [9] [10] [11] Occult metastases are conventionally treated by removal of the lymph nodes by elective neck dissection (END) after research showed higher rates of overall and disease-specific survival compared to a watchful waiting strategy. 12 However, an END has disadvantages: it leads to overtreatment in 63%-77% of the cases and has a risk of postoperative comorbidity (eg shoulder pain, reduced limb movement). 13 Therefore, there is a need for a better neck staging modality.
The sentinel lymph node biopsy (SLNB) was introduced in oral cavity cancer as a less invasive lymph node staging technique after successful implementation in melanoma and breast cancer. 5 The limited number of lymph nodes (LN) with the SLNB enables a more meticulous pathological examination incorporating step serial sectioning (SSS) and additional immunohistochemistry (IHC). 14 Recently, Liu and Wang reported a meta-analysis of 3566 early stage OSCC patients from 66 studies with a pooled sensitivity of 87% and negative predictive value (NPV) of 94% for SLNB in detecting occult metastasis. 15 However, many of these studies consist of small cohorts and differ in reference treatment, SLNB localisation technique (eg use of gamma probe, blue dye or single photon emission CT (SPECT-CT)) and pathological work-up (with or without IHC or SSS). Furthermore, several studies provide incomplete clinico-pathological information. This heterogeneity and lack of complete data underline the need for more studies using complete and homogeneous cohorts. The aim of this study was to determine the sensitivity and NPV of the SLNB in detecting occult metastases in a large, well-defined cohort. For this purpose, we used a retrospective cT1-2N0 OSCC cohort of 91 patients all treated by primary surgical resection, neck staging with the SLNB procedure and routine follow-up as reference standard for the SLNB negative neck.
| PATIENTS AND METHODS

| Ethical consideration
Sentinel lymph node biopsy was part of standard treatment and data were retrospectively gathered from existing data sources; therefore, no approval from the hospital research ethics board was required according to the Dutch ethical regulations. Detailed information about the patient selection and the SLNB procedure are added to this manuscript as Appendix S1.
Briefly, inclusion criteria were as follows: clinically T1-2 and N0
staged OSCC (7th TNM classification); primary treatment by surgical resection and neck staging by SLNB. Clinico-pathological data of the 91 (100%) patients were retrospectively collected from the digital patients files (Table 1) . Cases with a positive SNLB underwent a modified radical neck dissection (MRND) during a second surgery. Routine follow-up of the neck was used as reference standard in the SLNB negative patients and consisted of physical examination that was followed by ultrasound fine needle aspiration cytology (USFNAC) in case of enlarged (>1 cm) or otherwise suspicious lymph nodes.
| Study procedure
The SLNB procedure was described in detail before and was mostly the same in both centres. 18 Lymphoscintigraphy and SPECT/CT scans were made 1 day before surgery. Intraoperatively, SLNs were harvested after gamma probe assisted localisation. 18 
Keypoints
• The sentinel lymph node biopsy detected occult metastases in our cN0 cohort with an 85% sensitivity and a 94% negative predictive value.
• No additional metastases were seen in the neck dissection lymph nodes of patients with micrometastases or isolated tumor cells in the sentinel lymph nodes.
• The sentinel lymph node biopsy reveals unexpected lymphatic drainage patterns and therefore prevents patients for undertreatment of the neck.
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| RESULTS
Sentinel lymph nodes were identified in all 91 cases (100%). In total,
274 SLNs were harvested with a median of 3 (range 1-11) per patient. The results of the SLN procedures are summarised in Table 1 . In all patients, at least one SLN was intraoperatively (Table 1) .
| Follow-up and regional recurrence
Overall the median FU was 32 months (IQR 21-47, Range 2-104, Table 1 ). All patients with a follow-up <10 months died. In total,
8 (9%) patients of this cohort died. Three patients died of disease, two 10 months and one 21 months after the initial treatment.
T A B L E 1 Patient and tumour demographic characteristics
Demographic characteristics
Overall, n (%) Due to the four IRRs, the SLNB detected occult metastases with 85% sensitivity and 94% NPV.
| DISCUSSION
| Synopsis of key findings
In our retrospective cohort of 91 patients treated for cT1-2N0
OSCC, 4 patients developed isolated regional recurrence on the side of a negative SLNB. This resulted in 85% sensitivity and 94% negative predictive value.
| Comparison to previous studies
The sensitivity and NPV are in agreement with the results of other studies with routine follow-up as a reference: sensitivity range 80%-94% and NPV range 88%-97.5% (number of patients 59-415).
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A recent meta-analysis also showed comparable results: sensitivity 87%, NPV 94%. 15 The slightly higher NPV of this cohort compared to these meta-analyses can be explained by the relative short follow-up of some patients in our cohort. Two of the 66 patients (3%) with routine follow-up after a negative SLNB were diagnosed with with other studies. 6, 8 Retrospectively, the reason for missing these regional metastases remains unclear; shine-through phenomenon and aberrant lymphatic drainage due to metastatic tumour in the SLNs might be involved. Another possible explanation might be micrometastases in lymph nodes, other than the SLN (skip metastases).
Other studies reported a lower sensitivity of the SLNB procedure in FOM tumours compared to other oral cavity subsites due to the shine-through phenomenon. 7, 8, 21, 22 One patient in this study had a FOM with an IRR resulting in an 80% sensitivity and a 96% NPV for in agreement with den Toom and our data presented in this paper, SLN metastasis size might be used to select patients for routine follow-up instead of MRND. 8 Besides the SSS itself, also the step interval size could be discussed. After the second international conference on SLNB, intervals of 150 lm were recommended. 26 As was reported earlier for breast cancer, Jefferson et al suggested that SSS intervals of 2 mm are thin enough to detect micrometastasis. 27, 28 In this study, intervals of 500 lm were used, because our head and neck SCC protocol was adapted from our vulvar SCC SLNB protocol. This is a protocol we have much experience with and has shown to provide accurate staging of vulvar SCC in our centre. [29] [30] [31] Besides this, the accuracy we found is comparable to that of most head and neck SLNB studies. 15 Moreover, the ITC, microand macrometastasis ratio is comparable with other studies, indicating that we did not miss ITCs using this protocol. We therefore assume that this protocol has not influenced our results. However, with multiple comorbidities, a second operation with general anaesthesia is undesirable due to a higher complication and mortality chance. 33 Moreover, in all positive cases, scar tissue makes the neck dissection surgery more challenging in the SLN levels. To avoid repeat surgery, the possibility of intraoperatively staging of SLNs with frozen sections has been studied. 34 However, frozen sections have a substantial false negative rate; therefore, frozen sections of the SLNs are not applied in our centres. Also, a substantial amount of the SLN is lost for the FFPE sections and thereby increasing the risk of missing ITCs and micrometastases. 34 In an ideal situation, patients at high risk of lymph node metastases are preoperatively selected for MRND or watchful waiting. In the current study, an infiltrative tumour border configuration or a pT2 tumour was significantly associated with more regional metastases. Our research group reported earlier infiltration depth and lymphovascular invasion as independent predictors for nodal status in pT1-2N0 and N-status determination by routine HKD and watchful waiting. 35 These markers are not associated with positive lymph nodes in this study. The lack of significance could be explained by the difference in patient selection between the mentioned study by
Melchers (cN0 and cN+) and this study (cN0). 35 Therefore, the SLNB procedure is still more accurate in detecting occult metastasis in cT1-2N0 OSCC than the current clinical and pathological markers. In addition, it would be interesting to study the prognostic value of OSCC lymph node status associated biological markers such as WISP1, RAB25 or EpCAM in cT1-2N0 OSCC SLNB staged patients.
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| Study limitations
Limitation of this study is that the SLNB procedure was not part of the standard workflow for cT1-2N0 OSCC patients in the first years after introduction. If we analyse the accuracy without the 6 patients from this period, the sensitivity and NPV are still 85% and 94%
respectively.
